CPI-1612

CPI-1612 is a highly potent, orally active inhibitor of EP300/CBP histone acetyltransferase (HAT). It displays an IC50 of 8.0 nM for EP300 HAT. CPI-1612 suppresses H3K27 acetylation in vivo and exhibits efficacy in JEKO-1 mantle cell lymphoma xenograft at a low dose. CPI-1612 displays anticancer activity.

Price Not Available 5mg CPI-1612 Supplier Page
Catalog Number S6876
CAS# 2374971-81-8
Size 5mg
Supplier Page http://www.selleckchem.com/products/cpi-1612.html
Additional Information https://file.selleck.cn/downloads/struct/S6876-CPI-1612-chemical-structure.png